AbbVie Inc., it is one of the specialties biopharmaceutical companies that is known to
discover, develop, manufacture as well as commercialize drugs for complex and chronic
disease treatment. The drugs are indicated there for the treatment of different diseases.
Apart from it, with the advancement made by the company in the pipeline programs for
other concerns like cystic fibrosis, varied cancers, etc., the Abbvie share price forecast
now suggests a positive outlook for the upcoming years.
Further, AbbVie stock prediction has been showing the increased tendency. Hence, it
can be one of the best additions to the portfolio. As for the expert analysis considered
and the predictions made, it is based on different variables like price changes, similar
stocks, volume changes, and the market cycles.
In consideration of the above, this article has been prepared to provide AbbVie stock
forecast till 2030. Make sure you go through it once. However, do not base the entire
decision on it, as your personal analysis and research are quite important herein.
Read More :- Best Way to Invest 25k Short Term
AbbVie Stock Analysis
- The quarter 2 of 2022 of AbbVie earnings, it threw some negatives and positives
for the investors for contemplation. - The division of immunology looks quite strong. Even factoring in the patent cliff,
it faced a $20 billion-selling Humira, giving a positive outlook and a better
expectation for the AbbVie stock forecast. - Even neurology, too, looks quite strong, even though the aesthetics, along with
oncology and eye care, have given something to prove. - It was expected that AbbVie would be generating the CAGR growth (high-single-
digit) from the 2025 to the decade’s end after the revenue would fall in the year
2023 because of Humira LOE. - Over the next 52 weeks, the company AbbVie was, on average, historically risen
by around 15.3%, which is based on the past 10 years of the stock performance. - AbbVie got risen higher in 7 out of 10 years over a subsequent 52-week period,
which corresponds to the historical accuracy of around 70%. - As per the detailed modeling, it has been suggested that there has been around
15 to 20% on the upside for looking forward to in case of short term, and the
stock of ABBV, it remains the quite solid for the long-term buying opportunities
for the investors.
Financial Metrics of AbbVie
| AbbVie Stock Price Valuation Measures | Price/Value |
| Market Capital | $288.25 billion |
| 52 Week High | $171.07 |
| 52 Week Low | $124.73 |
| YTD% change | -0.11 |
| Enterprise Value/EBITDA | 13.67 |
| Enterprise Value/Revenue | 5.99 |
| S&P500 52-Week Change | -19.78% |
| Price/Sales (ttm) | 5.01 |
| Price/Book (mrq) | 18.03 |
| Profit Margin | 23.19% |
| Operating Margin | 37.21% |
Abbvie Stock Price Chart – https://walletinvestor.com/stock-forecast/abbv-stock-prediction
Abbvie stock forecast 2023
| Year | AbbVie Stock Prediction 2023 |
| 2023 | $192.415 |
According to the available data and AbbVie share price forecast, the maximum price of
the share can go to $192.415 while the minimum is estimated to stay at $189.175. The
shares are expected to see a 1.68% increase as part of the change in the share price. So,
if you are planning to make a purchase, now is the time to add AbbVie stocks to the
portfolio.
ABBV Stock Forecast 2025
| Year | AbbVie Stock Forecast 2025 |
| 2025 | $250.202 |
AbbVie stock price target suggests that the maximum stock price will go up to $250.202
while the minimum will remain up to $246.865. The percentage increase in the price of
the stocks is 1.33% in comparison to its previous share price.
If you are planning to get AbbVie shares, go ahead and do not delay. However, instead of
basing your entire decision on the forecast provided by our end, make sure to do personal research. If needed, take advice from the financer too. They will be able to give
better suggestions and ideas.
AbbVie Stock Forecast 2027
| Year | AbbVie Stock Prediction 2027 |
| 2027 | $307.081 |
Data collected through research and personal analysis brings us closer to an estimated
result that can be obtained, and in respect to 2027, Abbv stock forecast suggests that the
maximum price of the shares will go up to $307.081 and the minimum price will go up
till $304.456.
In comparison to the previous years, the percentage change shown in the share value is
just 0.86%, but the same is positive. It can bring in some good value to the holders of the stocks of AbbVie. So, if you have considered AbbVie to be added to the portfolio, do not back out. It is a great stock and can yield high returns.
Read More :- 5 Best Growth Stocks of 2023
AbbVie Stock Forecast 2030
| Year | AbbVie Stock Prediction 2030 |
| 2030 | $450+ |
Based on the past trends, analysis, and the expert's provided information, the data
suggests that the price of AbbVie shares can go up to $450 or beyond. However, to see such changes, one would be required to hold on to the shares till the end. If needed,
keep taking advice from the financer and never back out from the personal research.
They are very useful and help you to make the right decision at the right time.
Also Read :- Shiba inu price forecast | Shiba inu coin fundamental analysis
FAQ
Abbvie stock buy or sell?
Abbvie stocks have been showing the versatility and strength, even when all the other
businesses have been struggling badly. Considering this to be a positive sign for the
investors, Abbv stock forecast demonstrates that the stock is a safe stock to hold-buy
and then hold for many more upcoming years.
Does Warren Buffett own Abbvie?
No. AbbVie is not owned by Warren Buffett, who started building up a position in the
AbbVie in 2020 Q3, and he continued to make an investment till 2020 Q4. It is highly likely that he bought the stocks as he perceived the price to be below the intrinsic value
and sold the same when it was believed by him that the price was quite above the value.
It is to be noted that Warren Buffett is quite fond of the long-term holdings like the
short-term turnarounds, which are fairly common within the classical value investment.
Who owns the most Abbvie stock?
Like any other company, AbbVie stocks too are owned by the shareholders. In the case
of AbbVie, the below-mentioned are the 3 top stockholders with the total value
mentioned below,
- The Vanguard Group, Inc.- $23,932,004, 305 (8.40%)
- BlackRock Fund Advisors- $13,810,690,893 (4.85%)
- SSgA Funds Management, Inc.- $12,489,244,574 (4.38%)
What is the target price for Abbvie stock?
As per the analysts who offered a 12-month Abbvie share price forecast that has the
median target of $158.50. Further, the high estimate is $200.00, and the low estimate is
$135.00. Median estimates, it represents a -2.76% decrease from that of the last price,
which was $163.
Also Read :- How Can You Create and Sell NFTs for Free ?
Final Words
AbbVie is an American company that has been showing positive returns on the shares.
However, it is not easy to decide whether to include a share within a portfolio or to
remove it. This is why an estimate or, rather, a forecast has been provided above to
make sure one can have all the needed information to make the decision. However, do
not base the decision entirely on it, as these are just the estimated values, and it is
subject to market change. It can increase or decrease at any time. So, do personal
research before making any investment.
All the best!
Also Read :- Meta stock forecast
Disclaimer
The stocks forecast/target given/price prediction on the website, it is all for just to offering information and also to educate the stock market participants/investors/traders.
The content offered herein through the website, it must not be considered as any kind of financial advice or advice for making investments. So, one must make sure to do personal research as well as analysis instead of acting on comments for stocks.
Investing and Trading, they involve very high risk, and therefore, it is suggested to consult a financial advisor before you go ahead and make any decision. No responsibility would be taken by us for the consequences that result from acting on the comments.
